Pharma, Biotech, and CRO Consulting Services
Cagley Johnson Consulting Inc. (CJC)
greg@cagleyjohnson.com
leslie@cagleyjohnson.com
+1 (250) 516-3153
The Lancet Commission on prostate cancer: planning for the surge in cases - The Lancet https://t.co/HpGspArEyB
— Cagley Johnson Consulting Inc. (@cagleyjohnson) April 5, 2024
Cancer-vaccine trials give reasons for optimism https://t.co/h5MVap8QNM
— Cagley Johnson Consulting Inc. (@cagleyjohnson) March 28, 2024
CAR-T therapy for multiple sclerosis enters US trials for first time https://t.co/3cYzJCOWgh
— Cagley Johnson Consulting Inc. (@cagleyjohnson) February 24, 2024